Akums Wins European CEP Approval for Cefpodoxime Proxetil API
The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the stringent requirements of the European Pharmacopoeia.
The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the stringent requirements of the European Pharmacopoeia.
The company says its new genomic newborn screening service analyzes 595 carefully selected genes associated with childhood-onset conditions where early intervention may improve outcomes.
SKIA plans to enter the US market through a strategic partnership with hardware provider Structure.
With the FDA approval, Haisco’s Cipepofol becomes the first China-originated innovative intravenous anesthetic to enter the global market.
India’s healthcare, pharmaceutical, and medical device industries are set for another dynamic year in 2026, with several major conferences, expos, and summits taking place across the country.
The revised sampling guidelines mandate that every Drugs Inspector collect at least 10 samples per month.
If approved, Zydus Therapeutics plans to launch saroglitazar in the United States in Q4 of FY 27.
Unlike many existing treatments for fatty liver disease that mainly focus on weight loss, this new experimental drug targets the disease process itself.
WHO advisory groups recommend prioritizing three candidate therapeutics for Bundibugyo Ebola trials: Mapp Biopharmaceutical’s MBP134, Regeneron’s Maftivimab, and Gilead Sciences’ antiviral remdesivir.
While medications remain the first-line treatment for trigeminal neuralgia, CyberKnife-based stereotactic radiosurgery can offer significant relief when conventional therapies fail.